立方製藥(003020.SZ)IPO的初步詢價時間為11月5日及6日
格隆匯 11 月 2日丨立方製藥(003020.SZ)發佈首次公開發行股票初步詢價公告,擬公開發行新股2316萬股,佔發行後總股本的比例為25%。此次發行人股東不公開發售其所持股份,且發行的股票無流通限制及鎖定安排。
此次發行採用網下向符合條件的投資者詢價配售(“網下發行”)和網上按市值申購方式向社會公眾投資者定價發行(“網上發行”)相結合的方式進行。網下初始發行數量為1,389.60萬股,佔此次發行總量的60%;網上初始發行數量為926.4萬股,佔此次發行總量的40%。
此次發行初步詢價時間為2020年11月5日(T-5日)及2020年11月6日(T-4日)每日9:30~15:00,在上述時間內,欲參與網下發行的符合條件的網下投資者應在網下發行電子平台為其所管理的配售對象填寫報價以及擬申購數量等信息。每個配售對象只能有一個報價,同一機構管理的不同配售對象報價應當相同。配售對象報價的最小單位為0.01元。配售對象報價對應的擬申購數量應不少於100萬股,必須為10萬股的整數倍,且不得超過300萬股。投資者應按規定進行初步詢價,並自行承擔相應的法律責任。
投資者在2020年11月12日(T日)進行網上和網下申購時無需繳付申購資金。此次網下發行申購日與網上申購日同為2020年11月12日,其中,網下申購時間為9:30-15:00,網上申購時間為9:15-11:30,13:00-15:00。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.